Is Risperidone an Effective Option for Depression?

Risperidone is an antipsychotic, built for conditions like schizophrenia, yet it turns up regularly in depression care.¹ It is used as a booster for an antidepressant that hasn’t done enough on its own. For people stuck with partial relief, it can tip the balance toward feeling well, though not for everyone and not without trade-offs. Among the antipsychotics used this way, it stands out less for raw symptom relief than for how people say it affects their daily life and how few quit over side effects.²³

How Risperidone Is Used for Depression

About a third of people with depression don’t get well on their first antidepressants, a situation often called treatment-resistant depression. So risperidone is usually considered after at least one antidepressant has failed to bring full relief.⁴

This use is “off-label,” which just means a drug is prescribed for a use that isn’t on its official label. It is legal and common. Risperidone’s label covers schizophrenia, bipolar disorder and irritability in autism, not depression. Insurance and pharmacy questions can follow from off-label use, so it helps to ask your doctor to note the reason on the prescription.

“Treatment-resistant” can sound final, but it only means the first treatments haven’t brought enough relief, and several other steps remain. Before adding a medicine, clinicians commonly check that the antidepressant was taken regularly, long enough and at an adequate dose, since a trial that was too short or too low may not count as a failure. Sleep problems, alcohol use or thyroid trouble can also keep depression going, so they are worth checking before concluding that a booster is needed.

Doses used off-label were often below those recommended for schizophrenia.⁵ One approach starts at 0.5 mg a day and rises to about 1.5 mg a day over a week.⁶ That is a fraction of the several milligrams used for psychosis, which helps keep side effects down.

It is usually a small tablet taken once or twice a day alongside the antidepressant you already take. Because the starting dose is small, some people feel almost nothing at first, and that is expected. Your prescriber adjusts the dose slowly, based on how you feel and what side effects you notice. Stopping the antidepressant could lose the partial benefit you already have, so ask your doctor before changing either medicine’s dose.

How Well It Works for Stubborn Depression

After 4 weeks, 52% of people who added risperidone reached remission, meaning their symptoms faded to a minimal level, versus 24% who added a dummy pill.⁷ The two groups were also moving closer together by the end, so some of the edge is speed rather than size.⁸ Improvement in people who responded to these add-ons tended to show up within about 4 weeks.⁹

The placebo group’s 24% is a reminder that some improvement comes with extra attention and time. The numbers describe groups, not you.

Remission is a tougher target than response. Response usually means symptoms dropped by a meaningful amount, often about half, so someone can respond and still feel clearly unwell. When you talk to your prescriber, describe your sleep, energy, interest and concentration specifically, because these often show whether you are truly near remission.

The evidence has gaps. Risperidone has fewer trial participants behind it than other antipsychotic add-ons.¹⁰ In the largest risperidone trial, the benefit was about 30% smaller at its original 4-week goal than at the 6-week result it highlighted.¹¹ So the true benefit may be somewhat smaller than headline numbers suggest.¹²

A realistic trial runs about four to six weeks before a doctor judges whether it is working. Sleep or anxiety may ease before mood lifts. A simple mood log lets you compare honestly week to week. If nothing has changed by then, ask whether to stop rather than raise the dose indefinitely.

How It Compares With Other Add-On Options

Aripiprazole, quetiapine, olanzapine and risperidone have all been tested as add-ons for depression.¹³ In one large review, risperidone was the only standard-dose option that didn’t cause more people than placebo to quit over side effects.¹⁴ Only risperidone and aripiprazole clearly improved daily functioning and quality of life, and risperidone did better than quetiapine on that measure.¹⁵ Quality-of-life measures ask about work, relationships and daily activities, so they capture things a symptom checklist misses.

People tend to notice different things across these drugs. Quetiapine is commonly linked with sleepiness, which some welcome at bedtime and others find hard to function with. Olanzapine is widely recognized for strong appetite and weight effects, a major reason it is often not chosen first. Aripiprazole is often associated with restlessness, a feeling of being unable to sit still, which is a different problem from sedation. Risperidone’s usual trade-offs are weight gain and, for some, hormone-related effects, so its profile is different, not absent.

Against non-antipsychotic boosters, it looks similar. In a comparison with thyroid hormone, buspirone, valproate and trazodone as add-ons, none worked clearly better than the others.¹⁶ Risperidone’s response rate was the lowest of the five, about 47% versus 57% to 62% for the rest, though the gap wasn’t reliable.¹⁷

Those other four aren’t antipsychotics, so they carry different risks. Valproate needs particular caution for anyone who could become pregnant. Since none clearly won, your health, preferences and other medicines should drive the choice.

Useful questions when choosing: which side effects matter most to you, such as weight, sleepiness or restlessness; whether you have diabetes, heart issues or weight concerns; what each option costs and whether insurance covers it; and whether switching antidepressants or adding therapy is an alternative.

Weight Gain and Other Side Effects

In people starting risperidone for schizophrenia, about 6 in 10 gained weight within 8 weeks, averaging about 1.35 kg.¹⁸ About 1 in 8 gained 7% or more of their body weight.¹⁹ And 1 in 10 developed metabolic syndrome, a cluster of weight, blood sugar, blood pressure and cholesterol problems.²⁰ Those patients took higher doses than are used for depression, so the risk may be lower for you.

Increased appetite is often an early sign worth noticing. Record your weight before you begin, then weigh yourself regularly in the first weeks so a trend shows up before it becomes large.²¹ Changes in hunger, cravings for sweet or starchy food and portion size often come before the scale moves.

Antipsychotic add-ons can carry other side effects that some people find unacceptable.²² Dizziness on standing caused one dropout in a young people’s trial.²³

Ask for weight, waist and blood pressure checks before starting, and for fasting blood sugar and cholesterol tests within the first few months. Report sudden hunger or quick weight gain early, along with stiffness, restlessness, breast changes or missed periods, all known effects of risperidone.

If side effects appear, don’t stop abruptly without talking to your doctor. A dose reduction may help.

How Long to Take It and Relapse

In older adults who got well with risperidone added, those who kept taking it went about 105 days before relapse, versus 57 days for those switched to placebo.²⁴ By 6 months more than half relapsed either way, 56% versus 65%, a difference that wasn’t reliable.²⁵ The treatment was well tolerated in that group.²⁶ Since these results came from older adults, they may not carry over directly to younger ones.

Stopping soon after you feel well is not always wise, since depression that has just lifted is vulnerable to returning, but staying on indefinitely means accepting ongoing side effects. A reasonable plan is a review at a set time.

Ask at the start how long your doctor expects you to take it. Tapering is usually gradual, and it helps to watch for early signs of returning depression after stopping.

Psychotic Depression, Bipolar Disorder and Young People

Psychotic depression is a severe form in which a person may hear voices or hold fixed false beliefs, such as being guilty of terrible things or being ill when they are not. When depression comes with hallucinations or false beliefs, adding risperidone, quetiapine or olanzapine improved both depression and psychotic symptoms over 8 weeks.²⁷ The three worked about equally and were equally well tolerated,²⁸ so the choice often comes down to side effects and personal circumstances. Antipsychotics are usually expected here, and treatment typically includes an antidepressant alongside, managed by a psychiatrist.

Bipolar depression occurs in people who also have manic or hypomanic episodes, and antidepressants alone can sometimes be risky for them. In bipolar I disorder, a long-acting injection of risperidone delayed new mood episodes versus placebo, but that protection held for manic highs, not depressive lows.²⁹ So people whose main problem is bipolar depression shouldn’t count on it for the lows. If your low moods are part of bipolar disorder, ask which medicines have specific evidence for the depressive side.

In children with severe irritability, risperidone reduced irritability and also improved depression in an open trial.³⁰ That trial had no comparison group, so it supports “can help” only. Young people need closer weight monitoring.

Why It Affects People Differently

Risperidone is broken down mainly by a liver enzyme called CYP2D6, which you may see named on a genetic test report. Genes decide how active the enzyme is, from little or none to very fast. People whose version works slowly had higher blood levels of risperidone.³¹ A standard dose can act like a higher one, so people with inactive versions showed more side effects, including a heart rhythm change seen on an ECG.³² That doesn’t mean the drug won’t work, only that the dose that suits you may be lower than typical.

Medicines can mimic this too. Some antidepressants, like fluoxetine and paroxetine, slow the liver enzyme that breaks down risperidone even in people whose genes are normal, so your antidepressant itself may raise risperidone levels. That is a main reason prescribers start low and check in after any change. Adding or stopping an enzyme-slowing medicine can shift levels, so mention any such change.

Tell your doctor every medicine you take, share the CYP2D6 result if you’ve had a pharmacogenetic test, and ask whether an ECG makes sense if you have heart concerns.